A Study of the Safety and Efficacy of Tofimilast in Adult Asthmatics
NCT00150397
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
112
Enrollment
INDUSTRY
Sponsor class
Conditions
Asthma
Interventions
DRUG:
Tofimilast
Sponsor
Pfizer